Auxora has been assessed in efficacy trials including the Phase IIb CARPO trial for SIRS and acute pancreatitis.
India's biotech boom, challenges, and strategic priorities for future growth in healthcare and life sciences discussed by ...
La Jolla, California Wednesday, October 15, 2025, 13:00 Hrs [IST] ...
Final data analysis from the Dimerix collaboration with PARASOL reinforces the company’s proteinuria-based endpoints in its phase III ACTION3 trial of lead drug DMX-200 in rare kidney disease Focal ...
UVI Appoints New Leadership Team to Drive Academic Excellence, Innovation, and Financial Stewardship
After 17 years of service to UVI, Kelly Harrigan has been appointed Board Liaison and Administrator, effective October 6. In ...
A novel disease prevention strategy—targeting a mosquito that spreads the dengue virus—significantly reduces both the ...
Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health ResearchVANCOUVER, British Columbia, Oct. 09, ...
Duke University researchers secured a $15M federal grant to expand Duke-PMA, an AI model predicting mental illness in ...
Children and adolescents who are infected with COVID-19 more than one time are at an increased risk of heart inflammation, blood clots, and other serious complications.
Celerion has achieved of a full AAHRPP (Association for the Accreditation of Human Research Protection Programs) reaccreditation for five years.
India's death toll from the novel coronavirus rose past 100,000 on Saturday, only the third country in the world to reach that bleak milestone, after the United States and Brazil, and its epidemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback